Huang A - Search Results

1

Glatiramer Acetate Complexed with CpG as Intratumoral Immunotherapy in Combination with Anti-PD-1.

Huang A, Groer C, Lu R, Forrest ML, Griffin JD, Berkland CJ. Huang A, et al. Mol Pharm. 2022 Nov 7;19(11):4357-4369. doi: 10.1021/acs.molpharmaceut.2c00730. Epub 2022 Oct 25. Mol Pharm. 2022. PMID: 36282296

2

Human intratumoral therapy: Linking drug properties and tumor transport of drugs in clinical trials.

Huang A, Pressnall MM, Lu R, Huayamares SG, Griffin JD, Groer C, DeKosky BJ, Forrest ML, Berkland CJ. Huang A, et al. J Control Release. 2020 Oct 10;326:203-221. doi: 10.1016/j.jconrel.2020.06.029. Epub 2020 Jul 14. J Control Release. 2020. PMID: 32673633 Review.

3

Constructing a Biomaterial to Simulate Extracellular Drug Transport in Solid Tumors.

Huayamares SG, Song JY, Huang A, Crowl SR, Groer CE, Forrest ML, Berkland CJ. Huayamares SG, et al. Among authors: huang a. Macromol Biosci. 2020 Dec;20(12):e2000251. doi: 10.1002/mabi.202000251. Epub 2020 Sep 13. Macromol Biosci. 2020. PMID: 32924274

4

Intratumoral Cancer Chemotherapy with a Carrier-Based Immunogenic Cell-Death Eliciting Platinum (IV) Agent.

Groer C, Zhang T, Lu R, Cai S, Mull D, Huang A, Forrest M, Berkland C, Aires D, Forrest ML. Groer C, et al. Among authors: huang a. Mol Pharm. 2020 Nov 2;17(11):4334-4345. doi: 10.1021/acs.molpharmaceut.0c00781. Epub 2020 Oct 8. Mol Pharm. 2020. PMID: 32975949 Free PMC article.

5

Glatiramer acetate enhances tumor retention and innate activation of immunostimulants.

Pressnall MM, Huang A, Groer CE, Huayamares SG, Laird Forrest M, Berkland CJ. Pressnall MM, et al. Among authors: huang a. Int J Pharm. 2021 Aug 10;605:120812. doi: 10.1016/j.ijpharm.2021.120812. Epub 2021 Jun 16. Int J Pharm. 2021. PMID: 34144136

6

Formulation and preclinical evaluation of a toll-like receptor 7/8 agonist as an anti-tumoral immunomodulator.

Lu R, Groer C, Kleindl PA, Moulder KR, Huang A, Hunt JR, Cai S, Aires DJ, Berkland C, Forrest ML. Lu R, et al. Among authors: huang a. J Control Release. 2019 Jul 28;306:165-176. doi: 10.1016/j.jconrel.2019.06.003. Epub 2019 Jun 4. J Control Release. 2019. PMID: 31173789 Free PMC article.

7

Antigen-specific immune decoys intercept and exhaust autoimmunity to prevent disease.

Griffin JD, Song JY, Huang A, Sedlacek AR, Flannagan KL, Berkland CJ. Griffin JD, et al. Among authors: huang a. Biomaterials. 2019 Nov;222:119440. doi: 10.1016/j.biomaterials.2019.119440. Epub 2019 Aug 19. Biomaterials. 2019. PMID: 31450159

8

Disrupting N-Glycosylation Using Type I Mannosidase Inhibitors Alters B-Cell Receptor Signaling.

Huang A, Kurhade SE, Ross P, Apley KD, Griffin JD, Berkland CJ, Farrell MP. Huang A, et al. ACS Pharmacol Transl Sci. 2022 Oct 25;5(11):1062-1069. doi: 10.1021/acsptsci.2c00153. eCollection 2022 Nov 11. ACS Pharmacol Transl Sci. 2022. PMID: 36407961 Free PMC article.

9

Strategies to Screen Anti-AQP4 Antibodies from Yeast Surface Display Libraries.

Huang A, Jin W, Fahad AS, Mussman BK, Nicchia GP, Madan B, de Souza MO, Griffin JD, Bennett JL, Frigeri A, Berkland CJ, DeKosky BJ. Huang A, et al. Antibodies (Basel). 2022 Jun 5;11(2):39. doi: 10.3390/antib11020039. Antibodies (Basel). 2022. PMID: 35735358 Free PMC article.

10

Mapping monoclonal anti-SARS-CoV-2 antibody repertoires against diverse coronavirus antigens.

de Souza MO, Madan B, Teng IT, Huang A, Liu L, Fahad AS, Lopez Acevedo SN, Pan X, Sastry M, Gutierrez-Gonzalez M, Yin MT, Zhou T, Ho DD, Kwong PD, DeKosky BJ. de Souza MO, et al. Among authors: huang a. Front Immunol. 2022 Sep 2;13:977064. doi: 10.3389/fimmu.2022.977064. eCollection 2022. Front Immunol. 2022. PMID: 36119018 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,800 results

Search Page

Filters